Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Angle Share Price
  4. Angle Share News
  5. UK Earnings, Trading Statements Calendar - Next 7 Days

Pin to quick picksAngle Share News (AGL)

Angle Information

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.00
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.50 (8.824%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 17.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 22nd Oct 2020 16:01

Friday 23 October 
Essentra PLCThird Quarter Results
Barclays PLCThird Quarter Results
London Stock Exchange Group PLCThird Quarter Results
InterContinental Hotels Group PLCThird Quarter Results
Airtel Africa PLCHalf Year Results
Avation PLCFull Year Results
Monday 26 October 
THG Holdings PLCThird Quarter Results
Tuesday 27 October 
Bloomsbury Publishing PLCHalf Year Results
Plus500 LtdThird Quarter Results
St James's Place PLCThird Quarter Results
HSBC Holdings PLCThird Quarter Results (at 0400 GMT)
Dechra Pharmaceuticals PLCTrading Statement
Whitbread PLCHalf Year Results
Shoe Zone PLCTrading Statement
BP PLCThird Quarter Results
Hunting PLCTrading Statement
First Derivatives PLCHalf Year Results
Renalytix AI PLCFull Year Results
ContourGlobal Group PLCTrading Statement
Wednesday 28 October 
John Laing Group PLCTrading Statement
Ibstock PLCTrading Statement
Gem Diamonds LtdTrading Statement
Elementis PLCTrading Statement
International Biotechnology Trust PLCFull Year Results
GlaxoSmithKline PLCThird Quarter Results (at midday)
Next PLCTrading Statement
Bank of Ireland Group PLCTrading Statement
Omega Diagnostics Group PLCTrading Statement
Itaconix PLCHalf Year Results
Thursday 29 October 
Royal Dutch Shell PLCThird Quarter Results
Angle PLCHalf Year Results
Standard Chartered PLCThird Quarter Results (at 0415 GMT)
WPP PLCTrading Statement
Helios Towers PLCThird Quarter Results
Smith & Nephew PLCTrading Statement
Lloyds Banking Group PLCThird Quarter Results
Travis Perkins PLCTrading Statement
KAZ Minerals PLCThird Quarter Production
BT Group PLCHalf Year Results
International Personal Finance PLCTrading Statement
Indivior PLCThird Quarter Results
Glanbia plcThird Quarter Results
Foxtons Group PLCTrading Statement
Evraz PLCTrading Statement
Smith & Nephew PLCThird Quarter Trading Statement
Proactis Holdings PLCFull Year Results
Hilton Food Group PLCTrading Statement
Verona Pharma PLCThird Quarter Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
14 Aug 2020 12:41

Angle's Parsortix Able To Predict Patients' Response To Treatment

Angle's Parsortix Able To Predict Patients' Response To Treatment

Read more
20 Jul 2020 20:03

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

Read more
20 Jul 2020 10:16

Angle's 'Parsortix' advantageous in breast cancer in new research

(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertaken in metastatic breast cancer (MBC), highlighting advantages of a 'Parsortix' liquid biopsy, compared to standard-of-care tissue biopsy.

Read more
25 Jun 2020 12:22

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Read more
18 Jun 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
10 Jun 2020 16:41

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

Read more
12 May 2020 18:54

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Read more
12 May 2020 08:58

Angle upbeat on recent research using 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago in Spain has published results of new work undertaken in head and neck cancer and non small cell lung cancer, on the potential utility of a liquid biopsy-based strategy to assess MET alterations on circulating tumour cells (CTCs).

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
28 Apr 2020 10:03

Angle works with skeleton R&D crew during lockdown

(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a research and development skeleton crew in Guildford.

Read more
31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Read more
31 Mar 2020 09:40

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid-19 pandemic.

Read more
3 Mar 2020 18:58

Angle Parsortix Test Used To Help Discover Brain Metastasis

Angle Parsortix Test Used To Help Discover Brain Metastasis

Read more
27 Feb 2020 14:09

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Read more
27 Feb 2020 12:42

Angle upbeat on recent Parsortix research out of Italy

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results of work assessing the performance of its 'Parsortix' system in renal cell carcinoma (RCC), demonstrating key advantages of Parsortix.

Read more
5678910111213

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.